The cerebral blood vessel relaxation medicine null which contains group I die phospholipase A2

摘要

PURPOSE:To effectively improve or prevent a cerebrovascular disease such as cerebrovascular constriction, cerebral infarction or cerebral apoplexy by administrating a medicine containing PLA2-I as the main component. CONSTITUTION:The cerebrovascular relaxant containing group I type phospholipase A2 (PLA2-I). It is suggested that relaxation due to PLA2-I is possibly carried out through a single receptor existing in a vascular smooth muscle cell and specific to PLA2-I.